Nutex Health is rated Buy, with a DCF-based price target of $199.31, offering 19.8% upside from $166.40. NUTX's revenue ...

BayVanguard Bancorp's ROTCE appears mediocre due to a one-time severance and surplus capital, but normalized ROA is strong.

Cryptocurrency markets have always been extremely sensitive to news. From exchange failures, technological upgrades, viral ...

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred Shares in Elon Musk’s rocket company SpaceX ...

Simple stock picking formulas can beat the market, but higher volatility and tracking error make them hard for investors to stick with.

The stock market is currently trading near its most expensive valuation ever. That's not an exaggeration. The last time the market was this richly valued, it was in the months preceding one of the ...

Shares in Elon Musk’s rocket company SpaceX halted their three-day slide that had erased $600 billion off its market value. SpaceX shares closed at $156.11 for a nearly 1% gain on Tuesday, making for ...

Lime, the Uber-backed electric scooter and bike sharing startup, has applied to list on the Nasdaq stock exchange. The company aims to raise $181.9 million, potentially valuing it at $1.8 billion.

Your editorial “The Warsh Era Begins at the Fed” (June 15) correctly argues that forward guidance and the proliferation of Federal Reserve commentary have weakened rather than strengthened the ...

A model from New Orleans prepares for cold weather after returning from a trip to Cancun. Coffee linked to significant new side effect, says massive study 50 years later, a tiny clue may solve the ...

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred Bed Bath & Beyond is looking to stage a ...

WASHINGTON, June 26 (Reuters) - Anthropic said on Friday that the U.S. government has allowed it to release its powerful Claude Mythos 5 artifical intelligence model to some "trusted" U.S.